NVO · Novo Nordisk A S

$45.61 -0.65 (-1.41%) At close · Aug 28

Market Cap

$204.52B

4.42B

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

309.06B +6.4%

FY2025

Net Income

102.43B +1.4%

FY2025

Gross Margin

80.98% -3.7pp

FY2025

Operating Margin

41.3% -2.9pp

FY2025

Operating Cash Flow

119.1B -1.5%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015
Revenue DKK	+20.4%	+19.5%	+11.1%	309.06B	290.4B	232.26B	176.95B	140.8B	126.95B	122.02B	111.83B	111.7B	111.78B	107.93B
Cost of Revenue DKK	+27.4%	+22.9%	+13.8%	58.79B	44.52B	35.77B	28.45B	23.66B	20.93B	20.09B	17.62B	17.63B	17.18B	16.19B
Gross Profit DKK	+19.0%	+18.7%	+10.6%	250.28B	245.88B	196.5B	148.51B	117.14B	106.01B	101.93B	94.21B	94.06B	94.6B	91.74B
Research & Development DKK	+29.3%	+27.5%	+14.4%	52.04B	48.06B	32.44B	24.05B	17.77B	15.46B	14.22B	14.81B	14.01B	14.56B	13.61B
General & Administrative DKK	+10.1%	+8.6%	+4.5%	5.97B	5.28B	4.86B	4.47B	4.05B	3.96B	4.01B	3.92B	3.78B	3.96B	3.86B
Depreciation & Amortization DKK	+30.8%	—	—	14.67B	8.55B	7.29B	6.55B	—	—	—	—	—	—	—
Operating Income DKK	+19.5%	+18.7%	+9.9%	127.66B	128.34B	102.57B	74.81B	58.64B	54.13B	52.48B	47.25B	48.97B	48.43B	49.44B
Interest Expense DKK	+4.2%	+20.9%	+1.1%	6.78B	7.35B	845M	5.99B	2.45B	2.62B	4B	1.76B	1.53B	726M	6.05B
Pretax Income DKK	+23.6%	+19.7%	+11.6%	130.54B	127.19B	104.67B	69.06B	59.08B	53.13B	48.55B	47.62B	48.68B	47.8B	43.48B
Income Tax DKK	+27.6%	+20.7%	+12.5%	28.11B	26.2B	20.99B	13.54B	11.32B	10.99B	9.6B	8.99B	10.55B	9.87B	8.62B
Net Income DKK	+22.6%	+19.4%	+11.4%	102.43B	100.99B	83.68B	55.53B	47.76B	42.14B	38.95B	38.63B	38.13B	37.93B	34.86B

Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $191.88B in buybacks, $288.65B in dividends.

Key facts CIK 353278 CUSIP 670100205 13F (30d) 861 filings 823 filers Visit website Investor relations